NCT07512362: Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease.
- State
- Under way
- Phase
- Phase 2
- People
- 10 planned
- Started
- 15 May 2026
- Primary completion
- 15 Jun 2028
- Arms
- Mesenchymal Stem Cell Infusion
- Results
- None posted
- 6 Apr 2026: Trial registered
- 15 May 2026: Trial started